PMV Pharmaceuticals Inc (PMVP)
1.625
+0.02
(+0.93%)
USD |
NASDAQ |
Apr 18, 16:00
1.625
0.00 (0.00%)
After-Hours: 16:44
PMV Pharmaceuticals Total Assets (Quarterly): 252.15M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 252.15M |
| September 30, 2023 | 261.03M |
| June 30, 2023 | 242.22M |
| March 31, 2023 | 253.96M |
| December 31, 2022 | 270.31M |
| September 30, 2022 | 284.98M |
| June 30, 2022 | 300.56M |
| March 31, 2022 | 315.01M |
| Date | Value |
|---|---|
| December 31, 2021 | 331.57M |
| September 30, 2021 | 344.18M |
| June 30, 2021 | 355.91M |
| March 31, 2021 | 354.39M |
| December 31, 2020 | 365.53M |
| September 30, 2020 | 374.45M |
| June 30, 2020 | 159.04M |
| December 31, 2019 | 103.03M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
103.03M
Minimum
Dec 2019
374.45M
Maximum
Sep 2020
285.52M
Average
292.77M
Median
Total Assets (Quarterly) Benchmarks
| Exelixis Inc | 2.942B |
| Geron Corp | 394.08M |
| Verastem Inc | 149.72M |
| Karyopharm Therapeutics Inc | 240.44M |
| Kura Oncology Inc | 448.94M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 26.46M |
| Shareholders Equity (Quarterly) | 225.69M |